The Miller School at ENDO 2025
Miller School researchers made significant contributions to ENDO 2025, showing their influential work in endocrinology.
The ENDO 2025 conference was a landmark event in endocrinology, attracting over 7,000 attendees from around the globe. With nearly 2,500 abstracts and more than 200 sessions, ENDO stands as the premier global meeting for endocrinology research and clinical care. The conference’s comprehensive program provided attendees with the opportunity to learn about the latest developments in hormone science and medicine from renowned investigators, clinicians and educators.
“The ENDO annual meeting is a premier global conference that brings together researchers, clinicians and trainees from more than 100 countries to share cutting-edge research and clinical advances in endocrinology,” said Ernesto Bernal-Mizrachi, M.D., professor of medicine and chief of the Division of Endocrinology, Diabetes and Metabolism at University of Miami Miller School of Medicine. “ENDO also supports career development through mentorship, networking and educational opportunities, while promoting international scientific exchange and engagement with industry and policymakers. The Miller School made major contributions to the program, underscoring the excellence of our faculty, trainees and fellowship program. Our presence at this meeting underscores the exceptional quality of our faculty and fellows and distinguishes our program among peers.”
The ENDO 2025 education program featured three plenary sessions on genomics and health care, obesity care and women’s reproductive health. Additionally, the program included 75 symposium sessions, 40 “Meet the Professor” sessions, four master clinician panels and six “Meet the Scientist” sessions.
Five basic science pathways covered diabetes and metabolism, neuroendocrinology, receptor biology and signal transduction, reproductive endocrinology and a new pathway on tumor biology. The conference also featured a robust poster hall for accepted scientific abstracts.
The Miller School of Medicine made significant contributions to the conference, showing their influential work in endocrinology.
Dr. Lagari and Dr. Hannoush, both associate professors in the Division of Endocrinology, Diabetes and Metabolism, are program director and associate director, respectively, for the endocrinology fellowship program. They worked together to encourage fellows to attend the Endocrine Society conference and ensured they received the support they needed as they prepared their research for presentation. All fellows submitted posters of their research and notable case reports, contributing significantly to the field of endocrinology.
“We had a large turnout at Endocrine Society this year,” Dr. Lagari said. “This is important as it not only highlights the important work being done within the division but also engages our fellows to continue contributing to the field of endocrinology beyond their time in fellowship.”
Dr. Almaca, an associate professor in the Division of Endocrinology, Diabetes and Metabolism and an NIDDK-funded early-stage investigator, delivered an insightful talk, “Thinking Outside the Box to Cure Diabetes in the 21st Century: Perspectives from the Next Generation of Researchers,” on her research on pancreas pericytes and their role in pancreatic islets. Dr. Almaca shared valuable data on vascular control of islet function and research using living pancreatic tissue from organ donors with and without diabetes.
“It was important to share our data with the NIH and the endocrinology community, as well as the research we have been conducting using living pancreatic tissue from organ donors with and without diabetes,” said Dr. Almaca. “We are finding that this control may be disturbed very early during diabetes pathogenesis.”
“This is a significant honor,” said Dr. Bernal-Mizrachi. “On the 75th anniversary of NIDDK, this early-stage investigator symposium recognizes the creativity and scientific contributions of our next generation of researchers.”
Dr. Galindo, an associate professor in the Division of Endocrinology, Diabetes and Metabolism, chaired the 12th Annual Endocrine Fellows Conference: Type 1 Diabetes Care and Management. Dr. Galindo was responsible for the planning and development of the conference, providing scientific guidance, selecting faculty experts, advising on content development and reviewing presentations.
“This was a successful year, with more than 120 participants, including more than 30 international endocrine fellows from Asia, Latin America, Canada, Australia and Europe,” Dr. Galindo said. “Two of our own senior fellows from UM were selected for awards this year.”
Ernesto Bernal-Mizrachi, M.D.
Dr. Bernal-Mizrachi was a speaker at the “Liver Alpha Cell Axis Glucagon Resistance and Alpha Cell” symposium. Dr. Bernal-Mizrachi discussed the liver alpha cell axis in obesity, metabolic dysfunction-associated fatty liver disease (MAFLD) and diabetes, covering topics such as amino acid sensing in pancreatic islet alpha cells, regulation of glucagon secretion and the relevance of glucagon action to diabetes and MAFLD.
Dr. Jara, an assistant professor in the Division of Endocrinology, Diabetes and Metabolism, was recognized for his involvement with the Endocrine Society’s Trainee and Career Development Core Committee (TCDCC). The TCDCC focuses on supporting early-career endocrinologists by assessing their needs and offering resources and guidance to help them navigate their careers and advance in the field. The committee also organizes career development workshops and networking opportunities, such as the Early Career Forum at ENDO, and provides tools for grant writing and career advancement.
Tags: diabetes, diabetes and metabolism, Division of Endocrinology Diabetes and Metabolism, Dr. Ernesto Bernal-Mizrachi, Dr. Joana Almaca, Dr. Mark Jara, Dr. Rodolfo Galindo, Dr. Violet Lagari-Libhaber, Dr. Zeina Hannoush, Endocrine Society, endocrinology, Newsroom